{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:05:11Z","timestamp":1794330311818,"version":"4.9.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.semarthrit.2018.10.021","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T18:04:51Z","timestamp":1541181891000},"page":"140-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Positron emission tomography costs less to patients than conventional screening for malignancy in dermatomyositis"],"prefix":"10.1016","volume":"49","author":[{"given":"Avery","family":"Kundrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joslyn","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djibril","family":"Ba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galen","family":"Foulke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.semarthrit.2018.10.021_bib0001","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/mus.23302","article-title":"Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan","volume":"45","author":"Furst","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.semarthrit.2018.10.021_bib0002","first-page":"489","volume":"53","author":"Polymyositis","year":"1916","journal-title":"Berliner Klinische Wochenshrift"},{"key":"10.1016\/j.semarthrit.2018.10.021_bib0003","first-page":"335","article-title":"Primaire nichteitrige polymyositis","volume":"120","author":"Uber","year":"1916","journal-title":"Dtsch Arch Klin Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2018.10.021_bib0004","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3899\/jrheum.140566","article-title":"Polymyositis\/dermatomyositis and malignancy risk: a metaanalysis study","volume":"42","author":"Yang","year":"2015","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2018.10.021_bib0005","doi-asserted-by":"crossref","first-page":"R70","DOI":"10.1186\/ar2987","article-title":"Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan","volume":"12","author":"Chen","year":"2010","journal-title":"Arthr Res Ther"},{"issue":"12","key":"10.1016\/j.semarthrit.2018.10.021_bib0006","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","article-title":"Incidence of malignant disease in biopsy-proven inflammatory myopathy","volume":"134","author":"Buchbinder","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2018.10.021_bib0007","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2018.10.021_bib0008","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2133.2011.10595.x","article-title":"Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study","volume":"165","author":"Kuo","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semarthrit.2018.10.021_bib0009","first-page":"224","article-title":"Standardized incidence ratios and predictors of malignancies in 215 Southern Chinese patients with inflammatory myopathies","volume":"64","author":"Mok","year":"2012","journal-title":"Arthr Rheum"},{"issue":"12","key":"10.1016\/j.semarthrit.2018.10.021_bib0010","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3899\/jrheum.090549","article-title":"Malignancy is associated with dermatomyositis but not polymyositis in Northern New England, USA","volume":"36","author":"Antiochos","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.10.021_bib0011","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3109\/s10165-010-0362-y","article-title":"Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis","volume":"21","author":"Azuma","year":"2010","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.10.021_bib0012","first-page":"843","article-title":"An 11-year review of dermatomyositis in asian patients","volume":"39","author":"Liu","year":"2010","journal-title":"Ann Acad Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2018.10.021_bib0013","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1054\/bjoc.2001.1699","article-title":"Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study","volume":"85","author":"Stockton","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.semarthrit.2018.10.021_bib0014","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s10067-016-3296-8","article-title":"Malignancy in dermatomyositis and polymyositis: analysis of 192 patients","volume":"35","author":"Fang","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2018.10.021_bib0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1468-1331.2010.03220.x","article-title":"Screening for tumours in paraneoplastic syndromes: report of an EFNS task force","volume":"18","author":"Titulaer","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.semarthrit.2018.10.021_bib0016","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/bjd.12564","article-title":"Meta-analysis of the association of dermatomyositis and polymyositis with cancer","volume":"169","author":"Wang","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semarthrit.2018.10.021_bib0017","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00296-012-2489-y","article-title":"The incidence and associations of malignancy in a large cohort of patients with biopsy-determined idiopathic inflammatory myositis","volume":"33","author":"Limaye","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2018.10.021_bib0018","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1468-3083.2008.02971.x","article-title":"Clinical and biological factors predictive of malignancy in dermatomyositis","volume":"23","author":"Prohic","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.semarthrit.2018.10.021_bib0019","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archderm.138.7.885","article-title":"Routine vs extensive malignancy search for adult dermatomyositis and polymyositis","volume":"138","author":"Sparsa","year":"2002","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2018.10.021_bib0020","first-page":"77","article-title":"Dermatomyositis and malignancy: a retrospective study of 115 cases","volume":"13","author":"Zhang","year":"2009","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.semarthrit.2018.10.021_bib0021","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MD.0b013e31819da352","article-title":"Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis","volume":"88","author":"Fardet","year":"2009","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.semarthrit.2018.10.021_bib0022","first-page":"438","article-title":"Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study","volume":"35","author":"Andras","year":"2016","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2018.10.021_bib0023","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM199202063260602","article-title":"Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study","volume":"326","author":"Sigurgeirsson","year":"1992","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2018.10.021_bib0024","doi-asserted-by":"crossref","first-page":"e9639","DOI":"10.1097\/MD.0000000000009639","article-title":"Evidence Supports blind screening for internal malignancy in dermatomyositis: data from 2 large US dermatology cohorts","volume":"97","author":"Leatham","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.semarthrit.2018.10.021_bib0025","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.amjmed.2009.11.012","article-title":"Conventional cancer screening versus PET\/CT in dermatomyositis\/polymyositis","volume":"123","author":"Selva-O'Callaghan","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2018.10.021_bib0026","article-title":"Should PET scanning replace current malignancy screening methods in dermatomyositis?","author":"Callen","year":"2010","journal-title":"NEJM J Watch"},{"issue":"3","key":"10.1016\/j.semarthrit.2018.10.021_bib0027","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ccm.2010.05.008","article-title":"Pulmonary manifestations of the idiopathic inflammatory myopathies","volume":"31","author":"Kalluri","year":"2010","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.semarthrit.2018.10.021_bib0028","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archdermatol.2010.134","article-title":"Interstitial lung disease in classic and skin-predominant dermatomyositis: a retrospective study with screening recommendations","volume":"146","author":"Morganroth","year":"2010","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2018.10.021_bib0029","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/14397595.2015.1054099","article-title":"Deep-inspiration breath-hold 18F-FDG-PET\/CT is useful for assessment of connective tissue disease associated interstitial pneumonia","volume":"26","author":"Uehara","year":"2016","journal-title":"Mod Rheumatol"},{"issue":"12","key":"10.1016\/j.semarthrit.2018.10.021_bib0030","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2169\/internalmedicine.51.6813","article-title":"18F-FDG PET\/CT useful for the early detection of rapidly progressive fatal interstitial lung disease in dermatomyositis","volume":"51","author":"Morita","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.semarthrit.2018.10.021_bib0031","unstructured":"CPI-all urban consumers: medical care in U.S. city average, All Urban. 2005-2017. Bureau of Labor Statistics."},{"issue":"8","key":"10.1016\/j.semarthrit.2018.10.021_bib0032","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.3899\/jrheum.111597","article-title":"Detection of inflammatory lesions by f-18 fluorodeoxyglucose positron emission tomography in patients with polymyositis and dermatomyositis","volume":"39","author":"Owada","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.10.021_bib0033","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2169\/internalmedicine.51.6813","article-title":"18F-FDG PET\/CT useful for the early detection of rapidly progressive fatal interstitial lung disease in dermatomyositis","volume":"51","author":"Morita","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.semarthrit.2018.10.021_bib0034","unstructured":"PET\/CT Scanning. Radiation Protection of Patients 2013 [cited 2017 5\/14]; Available from: https:\/\/rpop.iaea.org\/RPOP\/RPoP\/Content\/InformationFor\/HealthProfessionals\/6_OtherClinicalSpecialities\/PETCTscan.htm."},{"issue":"4","key":"10.1016\/j.semarthrit.2018.10.021_bib0035","first-page":"608","article-title":"Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET\/CT examinations","volume":"46","author":"Brix","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.semarthrit.2018.10.021_bib0036","first-page":"17","article-title":"Positron emission tomography in follow-up of cutaneous malignant melanoma patients: a systematic review","volume":"4","author":"Danielsen","year":"2014","journal-title":"Am J Nucl Med Mol Imaging"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017218301070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017218301070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T16:44:35Z","timestamp":1564159475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017218301070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0049017218301070"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2018.10.021","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Positron emission tomography costs less to patients than conventional screening for malignancy in dermatomyositis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2018.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}